IGF1 and metastatic prostate carcinoma: Our previous study demonstrated that the insulin-like growth factor-1 (IGF-1) and the cytochrome P450 aromatase (CYP19) polymorphisms were significantly associated with the cancer -specific survival of metastatic prostate cancer [10].